UNITED STATES of America, Appellee, v. Justin GREEN, Defendant, Appellant.
No. 11-2157.
United States Court of Appeals, First Circuit.
Decided Oct. 31, 2012.
701 F.3d 48
Linda M. Ricci, Assistant United States Attorney, with whom Carmen M. Ortiz, United States Attorney, was on brief for appellee.
Before HOWARD, STAHL, and LIPEZ, Circuit Judges.
STAHL, Circuit Judge.
A jury convicted defendant-appellant Justin Green of participating in an oxycodone distribution conspiracy, and he received a sentence of 210 months. On appeal, he raises several challenges to his conviction and sentence, the most important of which is that the district court erred in refusing to suppress evidence that Drug Enforcement Administration (DEA) agents obtained from Green‘s cellular telephone, without a warrant, two weeks after they seized the phone. We find that any error was harmless and therefore leave for another day the question of whether the agents’ activity was lawful under the Fourth Amendment. Because Green‘s other claims also lack merit, we affirm.
I. Facts & Background
Given that this appeal follows a conviction, we recount the facts in the light most favorable to the verdict. United States v. Poulin, 631 F.3d 17, 18 (1st Cir.2011).
In the fall of 2008, the DEA began investigating a suspected oxycodone trafficking operation in and around Fall River, Massachusetts. With the help of a cooperating witness, the DEA identified Gilberto Aguiar as one of the participants and received court authorization to intercept calls and text messages on Aguiar‘s cell phone, as well as on the phones of Aguiar‘s suspected supplier, Dimas Almeida, and Almeida‘s suspected supplier, Aaron Tripp. The DEA agents intercepted calls between Tripp and a man named Mark Carrolton, which revealed that Tripp was planning to travel to Florida to buy several hundred thousand dollars’ worth of pills. Carrolton arranged for an individual named “J” or “Justin” (later identified as the defendant, Justin Green) to supply Tripp with 30,000 30-milligram oxycodone pills and 2,500 80-milligram pills. Carrolton also arranged for a second supplier named “Twin” to provide Tripp with 500 80-milligram oxycodone pills.
Tripp‘s trip to Florida was delayed for a week or so, and on May 1, 2009, Carrolton received a text message from Green stating the following: “I cant [sic] hold these for any longer. My people are backed up and jumping down my throat. Im [sic] going to have [sic] get rid of them to someone else if he isnt [sic] @erious [sic].” Carrolton forwarded that message to Tripp, warning Tripp that he could not “buy much more time” and telling him to
On May 5, 2009, on his way down to Florida, Tripp was pulled over by local law enforcement officers in South Carolina, who seized $396,000 in cash from Tripp as part of a search of his vehicle. Later that day, the DEA agents intercepted a call from Tripp to Carrolton, in which Tripp reported what had happened and told Carrolton to “ditch” his phone. Carrolton responded that he would “call ‘J‘” and talk to Tripp later. Carrolton then made three attempts to reach Green‘s cell phone number. Carrolton also sent a text message to the same number that night.
On May 6, 2009, the DEA agents persuaded Tripp to cooperate with them. At the agents’ direction, Tripp placed several (recorded) calls to Carrolton and told Carrolton that he would return to Massachusetts for more money and then meet Carrolton and Green in Florida to complete the transaction as planned.
On May 7, 2009, at approximately 7:30 p.m., Tripp once again called Carrolton, to finalize the plans for the drug deal. Shortly thereafter, Carrolton and Green arrived at a Holiday Inn Express in Fort Lauderdale, where the DEA agents had arranged for Tripp to rent a room. When Carrolton and Green (who arrived separately) knocked on Tripp‘s hotel room door, the DEA agents opened the door and identified themselves. Green ran down the hallway, but the agents stopped him and arrested him. The agents also arrested Carrolton.
At the time of the arrests, the DEA agents seized a cell phone, backpack, and two bags of pills from Carrolton (containing 748 30-milligram oxycodone pills and 442 80-milligram oxycodone pills). Carrolton later testified at trial that “Twin” had supplied some of those pills and that the rest were from Green. The agents also seized two cell phones from Green: a black MetroPCS Samsung phone and a Blackberry device.
Two weeks after Green‘s arrest, on May 21, 2009, DEA Special Agent Carl Rideout, by then back in Massachusetts, removed the back outside casing and battery from each of Green‘s cell phones and retrieved the International Mobile Subscriber Identity (IMSI) number from each.1 Agent Rideout did not have a warrant. According to the government, the “DEA agents used the IMSI numbers to obtain toll and subscriber information (including the telephone numbers) for the cellular telephones. Agents learned, among other things, that the telephone number associated with Green‘s MetroPCS black Samsung cellular telephone was (954) 245-2759.”
In June 2009, Green, Carrolton, Tripp, and others were charged with conspiring to possess with intent to distribute and to distribute oxycodone, a Schedule II controlled substance, in violation of
At trial, Carrolton and Tripp testified against Green, as did a man named William Conda, who had obtained oxycodone from Green in the past and who introduced Green to Carrolton. After a four-day trial, the jury convicted Green. The district court imposed a below-guideline sentence of 210 months in prison and three years of supervised release. This appeal followed.
II. Analysis
Green raises four claims on appeal. First, he argues that the district court should have granted his motion to suppress, because the DEA agents’ retrieval of his IMSI number from his cell phone constituted a Fourth Amendment search. Second, he contends that the district court violated
A. The motion to suppress
In the typical case in which a defendant challenges the denial of a motion to suppress, we review the district court‘s factual findings for clear error and its legal conclusions de novo. United States v. Symonevich, 688 F.3d 12, 18 (1st Cir.2012). Here, however, we need not delve into the district court‘s decision, because we find that there was ample evidence to convict Green even without the information that the DEA agents obtained from his cell phone after his arrest.3
The question Green raises—whether the DEA agents’ retrieval of his IMSI number constituted a search within the meaning of the Fourth Amendment4—is not, in our view, an easy one. It implicates an important and developing area of Fourth Amendment law: the extent of the privacy interest that an individual has in his cell phone and cellular communications. See, e.g., United States v. Flores-Lopez, 670 F.3d 803 (7th Cir.2012); United States v. Finley, 477 F.3d 250, 258-60 (5th Cir.2007); cf. United States v. Jones, 565 U.S. 400, 132 S. Ct. 945, 957, 181 L. Ed. 2d 911 (2012) (Sotomayor, J., concurring). But we find this case to be the wrong vehicle for exploring those novel issues, both because the record is insufficiently developed and because, even assuming that a Fourth Amendment search occurred here, any error was harmless.
The admission of evidence obtained in violation of the Fourth Amendment is harmless if the government can “prove beyond a reasonable doubt that the error complained of did not contribute to the verdict obtained.” Chapman v. California, 386 U.S. 18, 24 (1967); see also United States v. Salimonu, 182 F.3d 63, 71 (1st Cir. 1999). The government urges us to apply a more lenient standard, claiming that the improper admission of evidence is harmless if it is “highly probable that the error did not influence the verdict.” United States v. Flores-de-Jesus, 569 F.3d 8, 27 (1st Cir.2009) (citation and internal quotation marks omitted). But, as we recently reiterated, “[t]here are two barometers for measuring harmless error in a criminal case,” and the stricter harmless-beyond-a-reasonable-doubt standard applies “to issues of constitutional dimension,” like the one presented here. United States v. Sasso, 695 F.3d 25, 29 (1st Cir.2012). Despite the fact that the government has articulated the wrong standard, however, it has satisfied the correct one.
The government maintains, and Green does not dispute, that if the district court had granted Green‘s motion to suppress, the only evidence that would not have been admitted at trial was that the particular Samsung cell phone that the agents seized from him on May 7, 2009 was assigned telephone number (954) 245-2759. Though the DEA agents did also obtain Green‘s toll records using his IMSI number, the government apparently did not use those records at trial. The government submitted a chart summarizing Carrolton‘s telephone contacts with Green, but that chart was based entirely on Carrolton‘s toll records, obtained with his consent.
The other piece of evidence that the DEA agents obtained using Green‘s IMSI number was that his telephone number was (954) 245-2759, but that evidence would still have come in at trial, through Carrolton‘s testimony and information obtained from Carrolton‘s phone with his
Furthermore, there was a great deal of other evidence connecting Green to the conspiracy. That evidence, discussed above and at more length below, included the trial testimony of co-conspirators Carrolton and Tripp, the intercepted wire communications between and among Green‘s co-conspirators, the fact that Green arrived at the Holiday Inn Express on May 7, 2009 for the expected drug transaction, and the fact that Green fled when the DEA agents confronted him.
We cannot imagine that the jury would have rendered a different verdict in the absence of the one, relatively minor, piece of evidence derived exclusively from the retrieval of Green‘s IMSI number: namely, that the particular phone he was carrying on the day he was arrested was assigned telephone number (954) 245-2759. We therefore find beyond a reasonable doubt that any error here did not contribute to the verdict, see Chapman, 386 U.S. at 24, and we leave the Fourth Amendment question for another day.
B. The testimony of William Conda
Green‘s second claim is that the district court should not have admitted the testimony of William Conda, who had prior drug dealings with Green leading up to Green‘s participation in the conspiracy, because Conda‘s testimony concerned events that occurred before the time period alleged in the indictment and thus implicated Green‘s “prior bad acts” under
The indictment in this case alleged that the conspiracy to distribute oxycodone took place “[b]eginning on an unknown date but at least by in or about October, 2008, and continuing thereafter until in or about May, 2009.” Conda testified to events that seem to have occurred from October 2004 through 2006 or 2007, arguably before the time period explicitly alleged in the indictment.6 The essence of Conda‘s testimony was that: a man named Bill introduced him to Green; Conda obtained oxycodone pills from Green; Conda met Carrolton through work in 2006 and began taking oxycodone pills with Carrolton after work; Conda acted as a middleman by obtaining pills for himself and Carrolton from Green; and Conda eventually introduced Carrolton to Green as his source for oxycodone.
Under
We can bypass the question of whether the “other acts” at issue here were intrinsic or extrinsic. They were, in any event, admissible under
C. The sufficiency of the evidence
Green‘s third claim is that the district court erred in denying his motion for judgment of acquittal. See
To support its conspiracy charge against Green, the government was required to prove beyond a reasonable doubt that: (1) a conspiracy existed; (2) Green knew of the conspiracy; and (3) Green voluntarily participated in the conspiracy.7 United States v. Díaz, 670 F.3d 332, 347 (1st Cir.2012). The government could meet that burden with direct or circumstantial evidence. Id. And while “knowledge of the broader conspiracy‘s existence is critical,” the government did not have to prove that Green had “knowledge of every other participant, or of the details of the conspiracy.” United States v. Franco-Santiago, 681 F.3d 1, 9 (1st Cir.2012) (citations and internal quotation marks omitted). The evidence against Green was more than sufficient; we recount just some of it here.
First, Conda‘s testimony detailed the formation of the conspiracy, describing how Carrolton met, and began obtaining oxycodone from, Green.
Second, Tripp testified that, during the time period charged in the indictment, he repeatedly traveled from New England to Florida to obtain escalating amounts of oxycodone pills from Green. Carrolton acted as the middle man, but Tripp met Green during those transactions and testified that he was aware that Green was the source of the oxycodone pills. Tripp testified that Green supplied him with “a few hundred” pills of oxycodone at a time and that, overall, he purchased between 100,000 and 125,000 pills from Green over the course of the conspiracy. Tripp then sold about ninety-five percent of the pills to Dimas Almeida, who was involved in the drug trade in Massachusetts.
Third, Carrolton testified that somewhere between ninety-five and ninety-eight percent of the pills that Tripp obtained through Carrolton came from Green. Those transactions occurred about a dozen times between early 2008 and May 2009. Carrolton testified that Tripp would fly to Florida to obtain the pills when the deals involved less than $150,000, but on at least three occasions, Tripp purchased more than $150,000 worth of pills from Carrolton and Green and thus drove to Florida in order to be able to conceal the money. According to Carrolton, Green set the price for the pills and was present for the majority of the transactions with Tripp.
Fourth, Green arrived at the Holiday Inn Express on May 7, 2009 for what Carrolton and Tripp testified was a planned drug transaction and fled when the DEA agents identified themselves. Carrolton‘s toll records and the intercepted wire communications between Green‘s co-conspirators provided further evidence of Green‘s participation in the oxycodone distribution ring.
We have held that “[t]he testimony of a single witness can be enough to support the government‘s case, and even the uncorroborated testimony of an informant may suffice to establish the facts underlying a defendant‘s conviction.” United States v. Meises, 645 F.3d 5, 12 (1st Cir.2011) (internal citations and quotation marks omitted). There was obviously much more than that in this case. Green cites United States v. Moran, 984 F.2d 1299 (1st Cir.1993), for the proposition that a mere buyer-seller relationship between himself, Tripp, and Carrolton was insufficient to establish Green‘s knowing and voluntary participation in the conspiracy. But in Moran, we suggested that “[a] pattern of sales for resale between the same persons, together with details supplying a context for the relationship, might well support a finding of conspiracy,” and that is exactly what the evidence demonstrated here. Id. at 1303; see also United States v. Rivera-Ruiz, 244 F.3d 263, 270 (1st Cir.2001) (“[W]here advanced plans are made regarding the sale of narcotics in wholesale quantities, the participants in the transaction may be presumed to know that they are part of a broader conspiracy.” (quoting United States v. Harris, 8 F.3d 943, 946 (2d Cir.1993))). A jury could reasonably have concluded that Green participated in the charged conspiracy. See Symonevich, 688 F.3d at 23.
D. The drug quantity calculation
Green‘s final claim is that the district court erred in calculating the drug quantity attributable to him as a result of his participation in the conspiracy.8
The presentence report (PSR), using the trial testimony of Carrolton and Tripp, held Green responsible for distributing at least 100,000 oxycodone tablets. That amounted to 3,000 grams of actual oxycodone, with a marijuana equivalency of 20,100 kilograms and a resulting base offense level (BOL) of 36. See
Tripp testified that he purchased between 100,000 and 125,000 pills from Green over the course of the conspiracy. The PSR used the lower number and assumed that all of those were 30-milligram pills, when in fact Tripp testified that Green also supplied 80-milligram pills. Green claims that there were other suppliers, but the only other supplier referenced was “Twin,” and Carrolton testified that somewhere between ninety-five and ninety-eight percent of the pills that Tripp obtained through Carrolton came from Green. We have held that a district court, in making a drug quantity determination, can “rely solely on the testimony of cooperating government witnesses, provided such testimony exhibits some indicia of reliability or support from the record.” United States v. Valdivia, 680 F.3d 33, 53 (1st Cir.2012); see also United States v. Rivera-Calderón, 578 F.3d 78, 100 (1st Cir.2009). Green has not challenged the drug quantity determination on the ground that his co-conspirators’ testimony lacked adequate indicia of reliability. There was no clear error. See Bernier, 660 F.3d at 545.
III. Conclusion
For the foregoing reasons, we affirm.
NORMAN H. STAHL
UNITED STATES CIRCUIT JUDGE
